Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100052392Phase 4Not yet recruiting
Phase 4, randomised trial of dexmedetomidine in Postoperative gastrointestinal dysfunction (POGD) (2 arms), sponsored by Bethune International Peace Hospital. Primary endpoint: Time to first flatus. Planned start Oct 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100052392.